Abstract
The aim of this study was to evaluate the contribution of cytological analysis of cerebrospinal fluid (CSF) in the diagnostic work-up of breast cancer patients who present with neurological symptoms suspected for central nervous system (CNS) metastases. In the period 1989–2009, a total of 81 patients with breast cancer underwent CSF cytological examination. Relevant tumour characteristics, clinical presentation and radiological findings were scored. The CSF cytological diagnosis was classified according to the 1996 NCI-sponsored conference approach as malignant, suspicious for malignancy, atypical, benign or inadequate. During the course of 20 years, 145 CSF cytological examinations were performed. Relatively common neurological symptoms resulting in cytological CSF examination were headache (n = 25), nausea and vomiting (n = 19), sensory disturbances (n = 16), and cranial nerve dysfunction (n = 16). Of these, headache and nausea/vomiting were most often associated with malignant cells in the CSF (CSF+) (in 48 and 53% of the cases, respectively). The 4 patients with both headache and confusion/altered mental status all had CSF+. In 10 patients, CSF+ was found despite the absence of radiological evidence for metastasis in/around the CNS. In our series, repeated CSF analysis appeared to have limited additional value, and CSF+ was strongly correlated with shorter survival. A substantial number of patients with neurological symptoms but without radiological abnormalities can have CSF+. In our series, the additional value of repeated cytological examination of CSF was limited. Our study underscores the value of CSF cytology as a tool for the unequivocal diagnosis of metastatic spread of breast cancer to the CNS, and confirms that CSF+ is a strong predictor of poor survival.
Similar content being viewed by others
References
Chamberlain MC (2005) Neoplastic meningitis. J Clin Oncol 23:3605–3613
Chamberlain MC (2009) Leptomeningeal metastasis. Curr Opin Neurol 22:665–674
GM Chamberlain MC (2005) Cerebrospinal fluid-disseminated meningioma. Cancer 103:1427–1430
Chamberlain MC, Kormanik PR (1997) Carcinomatous meningitis secondary to breast cancer: predictors of response to combined modality therapy. J Neurooncol 35:55–64
DeAngelis LM, Boutros D (2005) Leptomeningeal metastasis. Cancer Invest 23:145–154
Drappatz J, Batchelor TT (2007) Leptomeningeal neoplasms. Curr Treat Options Neurol 9:283–293
Grossman SA, Krabak MJ (1999) Leptomeningeal carcinomatosis. Cancer Treat Rev 25:103–119
Soffietti R, Akerley W, Jensen RL, Bischoff J, Regierer AC (2009) The role of intra-cerebrospinal fluid treatment and prophylaxis in patients with solid tumors. Semin Oncol 36(Suppl 2):S55–S68
Bendell JC, Domchek SM, Burstein HJ, Harris L, Younger J, Kuter I, Bunnell C, Rue M, Gelman R, Winer E (2003) Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer 97:2972–2977
Platini C, Long J, Walter S (2006) Meningeal carcinomatosis from breast cancer treated with intrathecal trastuzumab. Lancet Oncol 7:778–780
Graesslin O, Abdulkarim BS, Coutant C, Huguet F, Gabos Z, Hsu L, Marpeau O, Uzan S, Pusztai L, Strom EA, Hortobagyi GN, Rouzier R, Ibrahim NK (2010) Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer. J Clin Oncol 28:2032–2037
Slimane K, Andre F, Delaloge S, Dunant A, Perez A, Grenier J, Massard C, Spielmann M (2004) Risk factors for brain relapse in patients with metastatic breast cancer. Ann Oncol 15:1640–1644
Tham YL, Sexton K, Kramer R, Hilsenbeck S, Elledge R (2006) Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer 107:696–704
Niwińska A, Murawska M, Pogoda K (2010) Breast cancer brain metastases differences in survival: depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT). Cancer 116:4238–4247
Balm M, Hammack J (1997) Leptomeningeal carcinomatosis. Presenting features and prognostic factors. Arch Neurol 54:16–17
Heimann A, Merino MJ (1986) Carcinomatous meningitis as the initial manifestation of breast cancer. Acta Cytol 30:25–28
Wesseling P, von Deimling A, Aldape KD (2007) WHO classification of tumours of the central nervous system, chapter 15, 4th edn. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) Metastatic tumours of the CNS. IARC, Lyon, pp 248–251
Lee Y (1983) Breast carcinoma: pattern of metastasis at autopsy. J Surg Oncol 23:175–180
Tsukada Y, Fouad A, Pickren JW, Lane WW (1983) Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer 15:2349–2354
Yap HY, Yap BS, Tashima CK, DiStefano A, Blumenschein GR (1978) Meningeal carcinomatosis in breast cancer. Cancer 42:283–286
Casparie M, Tiebosch AT, Burger G, Blauwgeers H, van de Pol A, van Krieken JH, Meijer GA (2007) Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 29:19–24
The uniform approach to breast fine-needle aspiration biopsy (1997) NIH consensus development conference. Am J Surg 174:371–385
Dufour H (1997) Classics in cytology. VIII: diffuse meningeal sarcomatosis with invasion of the spinal cord, the spinal roots. Positive cytological results, especially of the cerebrospinal fluid, 1904. Diagn Cytopathol 17:67–69
Glass JP, Melamed M, Chernik NL, Posner JB (1979) Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology 29:1369–1375
Gleissner B, Chamberlain MC (2006) Neoplastic meningitis. Lancet Neurol 5:443–452
van Oostenbrugge RJ, Twijnstra A (1999) Presenting features and value of diagnostic procedures in leptomeningeal metastases. Neurology 53:382–385
Boogerd W, Hart AA, van der Sande JJ, Engelsman E (1991) Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment. Cancer 67:1685–1695
Boogerd W, van den Bent MJ, Koehler PJ, Heimans JJ, van der Sande JJ, Aaronson NK, Hart AA, Benraadt J, ChJ Vecht (2004) The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study. Eur J Cancer 40:2726–2733
Schellinger PD, Meinck HM, Thron A (1999) Diagnostic accuracy of MRI compared to CCT in patients with brain metastases. J Neurooncol 44:275–281
Seute T, Leffers P, ten Velde GP, Twijnstra A (2008) Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI). Cancer 112:1827–1834
Ba-Ssalamah A, Nöbauer-Huhmann IM, Pinker K, Schibany N, Prokesch R, Mehrain S, Mlynárik V, Fog A, Heimberger K, Trattnig S (2003) Effect of contrast dose and field strength in the magnetic resonance detection of brain metastases. Invest Radiol 38:415–422
Gupta RK, Naran S, Lallu S, Fauck R (2004) Cytodiagnosis of neoplasms of the central nervous system in cerebrospinal fluid samples with an application of selective immunostains in differentiation. Cytopathology 15:38–43
Jorda M, Ganjei-Azar P, Nadji M (1997) Cytologic characteristics of meningeal carcinomatosis: increased diagnostic accuracy using carcinoembryonic antigen and epithelial membrane antigen immunocytochemistry. Arch Neurol 55:181–184
Kranz BR (2000) Detection of rare malignant cells and their apoptotic fragments in cerebrospinal fluid. Lancet 356:1242–1244
Twijnstra A, Ongerboer de Visser BW, van Zanten AP, Hart AA, Nooyen WJ (1989) Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors. J Neurooncol 7:57–63
Twijnstra A, van Zanten AP, Nooyen WJ, Ongerboer de Visser BW (1986) Sensitivity and specificity of single and combined tumour markers in the diagnosis of leptomeningeal metastasis from breast cancer. J Neurol Neurosurg Psychiatry 49:1246–1250
van Oostenbrugge RJ, Hopman AH, Arends JW, Ramaekers FC, Twijnstra A (1998) The value of interphase cytogenetics in cytology for the diagnosis of leptomeningeal metastases. Neurology 51:906–908
Acknowledgments
The authors would like to thank Mrs. Chantal Huyben-van Leent for the excellent technical support and Mrs. I. de Kievit-van der Heijden, MD, PhD, for editing the text.
Conflict of interest
None.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
This retrospective study was conducted following the rules of the ethical committee of our centre.
Rights and permissions
About this article
Cite this article
Wauters, C.A.P., Poelen, J., Mulder, I. et al. Contribution of CSF cytology in the diagnostic work-up of breast cancer patients with neurological symptoms: a retrospective analysis over two decades. J Neurooncol 107, 581–589 (2012). https://doi.org/10.1007/s11060-011-0782-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-011-0782-3